enVVeno Medical Corporation (NVNO)Healthcare | Medical Devices | Irvine, United States | NasdaqCM
10.75 USD
-0.72
(-6.277%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 10.75 |
Hot Take ↕ | Aug. 22, 2026, 1:42 a.m. EDT
The immediate outlook is severely clouded by a negative statistical forecast predicting a 2.16% decline over the next 45 days, which aligns with the stock trading well below its 50-day moving average. While the company recently regained compliance with Nasdaq minimum bid requirements and reported narrower losses, the underlying business fundamentals are deteriorating rapidly. The enterprise has suffered a catastrophic 98% drop in value over the last seven years, with the most recent annual performance showing an 81% decline. Compounding this distress is a severe cash crunch; the company has burned through nearly $15 million in operating cash flow and carries a negative free cash flow of almost $10 million, leaving it with less than a year of runway despite raising capital. With no dividend to provide income and a balance sheet that cannot sustain operations without further dilution or financing, the investment case is currently non-existent. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.042084 |
| MSTL | 0.057149 |
| AutoTheta | 0.066430 |
| AutoETS | 0.066615 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 58% |
| H-stat | 0.35 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.305 |
| Excess Kurtosis | -1.12 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.443 |
| Market Cap | 7,469,379 |
| Forward P/E | -1.73 |
| Beta | 1.06 |
| Previous Name | Hancock Jaffe Laboratories, Inc. |
| Website | https://www.envveno.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6040162 |
| Address1 | 70 Doppler |
| All Time High | 4,935.0 |
| All Time Low | 8.67 |
| Ask | 13.56 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 15,940 |
| Average Daily Volume3 Month | 15,972 |
| Average Volume | 15,972 |
| Average Volume10Days | 15,940 |
| Beta | 1.055 |
| Bid | 7.78 |
| Bid Size | 2 |
| Book Value | 30.713 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 10.75 |
| Current Ratio | 11.702 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 10.75 |
| Day Low | 10.7 |
| Debt To Equity | 2.443 |
| Display Name | enVVeno Medical |
| Dividend Date | 1,606,694,400 |
| Earnings Timestamp End | 1,754,337,600 |
| Earnings Timestamp Start | 1,753,819,200 |
| Ebitda | -17,256,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.791 |
| Enterprise Value | -13,641,738 |
| Eps Current Year | -16.19 |
| Eps Forward | -6.22 |
| Eps Trailing Twelve Months | -24.97 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 10.73856 |
| Fifty Day Average Change | 0.011440277 |
| Fifty Day Average Change Percent | 0.0010653456 |
| Fifty Two Week Change Percent | -60.40162 |
| Fifty Two Week High | 35.7 |
| Fifty Two Week High Change | -24.95 |
| Fifty Two Week High Change Percent | -0.69887954 |
| Fifty Two Week Low | 8.67 |
| Fifty Two Week Low Change | 2.08 |
| Fifty Two Week Low Change Percent | 0.23990771 |
| Fifty Two Week Range | 8.67 - 35.7 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,527,773,400,000 |
| Float Shares | 551,516 |
| Forward Eps | -6.22 |
| Forward P E | -1.7282959 |
| Free Cashflow | -9,590,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 33 |
| Fullday Change | -0.72 |
| Fullday Change Percent | -6.27725 |
| Fullday Price | 10.75 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13081001 |
| Held Percent Institutions | 0.15955 |
| Implied Shares Outstanding | 694,826 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,768,867,200 |
| Last Split Factor | 1:35 |
| Long Business Summary | enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. |
| Long Name | enVVeno Medical Corporation |
| Market | us_market |
| Market Cap | 7,469,379 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_28089740 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -15,724,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 7,809,844 |
| Number Of Analyst Opinions | 1 |
| Open | 10.7 |
| Operating Cashflow | -14,622,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 949 261 2900 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 10.75 |
| Post Market Time | 1,787,959,806 |
| Prev Name | Hancock Jaffe Laboratories, Inc. |
| Previous Close | 11.47 |
| Price Eps Current Year | -0.6639901 |
| Price Hint | 2 |
| Price To Book | 0.35001466 |
| Profit Margins | 0.0 |
| Quick Ratio | 11.386 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.72000027 |
| Regular Market Change Percent | -6.2772474 |
| Regular Market Day High | 10.75 |
| Regular Market Day Low | 10.7 |
| Regular Market Day Range | 10.7 - 10.75 |
| Regular Market Open | 10.7 |
| Regular Market Previous Close | 11.47 |
| Regular Market Price | 10.75 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 3,073 |
| Return On Assets | -0.36675 |
| Return On Equity | -0.58533 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 694,826 |
| Shares Percent Shares Out | 0.0357 |
| Shares Short | 24,403 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 10,839 |
| Short Name | enVVeno Medical Corporation |
| Short Percent Of Float | 0.036 |
| Short Ratio | 1.3 |
| Source Interval | 15 |
| State | CA |
| Symbol | NVNO |
| Target High Price | 30.0 |
| Target Low Price | 30.0 |
| Target Mean Price | 30.0 |
| Target Median Price | 30.0 |
| Total Cash | 21,486,000 |
| Total Cash Per Share | 31.471 |
| Total Debt | 505,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -24.97 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 11.301175 |
| Two Hundred Day Average Change | -0.5511751 |
| Two Hundred Day Average Change Percent | -0.048771486 |
| Type Disp | Equity |
| Volume | 3,073 |
| Website | https://www.envveno.com |
| Zip | 92,618 |